Novel neuronal surface autoantibodies in plasma of patients with depression and 
anxiety

Zong, Shenghua; Correia-Hoffmann, Carolin; Mane-Damas, Marina; Kappelmann, Nils; Molenaar, Peter C.; van Grootheest, Gerard; Penninx, Brenda W. J. H.; Rouhl, Rob P. W.; Losen, Mario; Martinez-Martinez, Pilar

doi:10.1038/s41398-020-01083-y

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety

MPS-Authors

/persons/resource/persons227413

Kappelmann, Nils
Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;
IMPRS Translational Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Zong, S., Correia-Hoffmann, C., Mane-Damas, M., Kappelmann, N., Molenaar, P. C., van Grootheest, G., et al. (2020). Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety. TRANSLATIONAL PSYCHIATRY, 10(1): 404. doi:10.1038/s41398-020-01083-y.

Cite as: https://hdl.handle.net/21.11116/0000-0008-A6AF-8

Abstract

Neuronal surface autoantibodies (NSAbs) against various antigens cause autoimmune encephalitis. Some of these antigens are also involved in the pathology of depression and anxiety. To study whether NSAbs are more common in plasma of individuals with depression and anxiety than in controls, and to investigate if NSAbs correlate with disease status, plasma samples of 819 individuals with a current diagnosis of depression and/or anxiety, 920 in remission and 492 individuals without these disorders were included in this study. Samples were tested by a combination of immunohistochemistry (IHC), staining on live rat hippocampus neurons and cell-based assay (CBA). By IHC, 50 (2.2%) samples showed immunoreactivity to rat brain tissue, with no significant differences between the aforementioned groups (22/819 vs 18/920 vs 11/492, P > 0.99). In addition, eight IHC positive samples were positive for NSAbs on live neurons (7/819 vs 0/920 vs 1/492, P = 0.006). The IHC-staining patterns of these eight samples were atypical for autoimmune encephalitis and accordingly, they tested negative for known NSAbs by CBA. No obvious difference in the clinical characteristics between individuals with or without NSAbs was observed. In conclusion, novel NSAbs were rare but predominately found in patients with current anxiety or depression indicating they might affect mental health in a small group of patients.